Solvent-less ionic liquid epoxy resin

US11859077B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11859077-B2
Application numberUS-202117227223-A
CountryUS
Kind codeB2
Filing dateApr 9, 2021
Priority dateOct 25, 2016
Publication dateJan 2, 2024
Grant dateJan 2, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Solvent free epoxy system that includes: a hardener compound H comprising: a molecular structure (Y 1 —R 1 —Y 2 ), wherein R 1 is an ionic moiety Y 1 is a nucleophilic group and Y 2 nucleophilic group; and an ionic moiety A acting as a counter ion to R 1 ; and an epoxy compound E comprising: a molecular structure (Z 1 —R 2 —Z 2 ), wherein R 2 is an ionic moiety, Z 1 comprises an epoxide group, and Z 2 comprises an epoxide group; and an ionic moiety B acting as a counter ion to R 2 . In embodiments, the epoxy compound E and/or the hardener H is comprised in a solvent-less ionic liquid. The systems can further include accelerators, crosslinkers, plasticizers, inhibitors, ionic hydrophobic and/or super-hydrophobic compounds, ionic hydrophilic compounds, ionic transitional hydrophobic/hydrophilic compounds, biological active compounds, and/or plasticizer compounds. Polymers made from the disclosed epoxy systems and their methods of used.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of preparing a diamine imidazolium halide, the method comprising: reacting a haloalkylamine with a triphenylmethyl halide to yield a protected haloalkylamine, wherein the haloalkylamine is a primary amine and the protected haloalkylamine is a secondary amine; reacting the protected haloalkylamine with an alkylimidazole to yield a bisubstituted alkylimidazole; removing the triphenylmethyl from the bisubstituted alkylimidazole to yield a halide derivative of the bisubstituted alkylimidazole; and neutralizing the halide derivative of the bisubstituted alkylimidazole to yield the diamine imidazolium halide, wherein: the haloalkylamine is bromoethylamine, the triphenylmethyl halide is tritylchloride, the protected haloalkylamine is bromoethyltriphenylmethylamine; the alkylimidazole is 2-methylimidazole, and the diamine imidazolium halide is 1,3-di(2′-aminoethylene)-2-methylimidazolium bromide. 2. The method of claim 1 , wherein reacting the haloalkylamine with the triphenylmethyl halide occurs in the presence of triethylamine and dichloromethane. 3. The method of claim 1 , wherein reacting the protected haloalkylamine with the alkylimidazole occurs in the presence of sodium hydride and dimethylformamide. 4. The method of claim 1 , wherein removing the triphenylmethyl from the bisubstituted alkylimidazole occurs in acidic media. 5. The method of claim 1 , wherein neutralizing the halide derivative of the bisubstituted alkylimidazole occurs in basic media. 6. An ionic liquid comprising the diamine imidazolium halide of claim 1 . 7. The method of claim 1 , wherein the 1,3-di(2′-aminoethylene)-2-methylimidazolium bromide is a hardener compound of an ionic liquid epoxy system. 8. The method of claim 7 , wherein the 1,3-di(2′-aminoethylene)-2-methylimidazolium bromide is configured to react with an ionic epoxy compound of the ionic liquid epoxy system. 9. The method of claim 8 , wherein the ionic epoxy compound comprises: a molecular structure (Z 1 —R 2 —Z 2 ), where R 2 is an ionic moiety, Z 1 comprises an epoxide group, and Z 2 comprises an epoxide group; and an ionic moiety B acting as a counter ion to R 2 . 10. A method comprising: preparing 1,3-di(2′-aminoethylene)-2-methylimidazolium bromide according to the method of claim 9 ; preparing the ionic liquid epoxy system with the 1,3-di(2′-aminoethylene)-2-methylimidazolium bromide as a hardener compound; and reacting the 1,3-di(2′-aminoethylene)-2-methylimidazolium bromide with the ionic epoxy compound to yield a polymer. 11. The method of claim 10 , wherein the polymer is suitable as a component of a battery.

Assignees

Inventors

Classifications

  • C08L63/00Primary

    Compositions of epoxy resins; Compositions of derivatives of epoxy resins · CPC title

  • aromatic · CPC title

  • containing sulfur · CPC title

  • containing phosphorus · CPC title

  • containing an atom other than nitrogen belonging to the amine group, carbon and hydrogen · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11859077B2 cover?
Solvent free epoxy system that includes: a hardener compound H comprising: a molecular structure (Y 1 —R 1 —Y 2 ), wherein R 1 is an ionic moiety Y 1 is a nucleophilic group and Y 2 nucleophilic group; and an ionic moiety A acting as a counter ion to R 1 ; and an epoxy compound E comprising: a molecular structure (Z 1 —R 2 —Z 2 ), wherein R 2 is an ionic moiety, Z 1 comprises an epoxide gr…
Who is the assignee on this patent?
Univ Arizona State
What technology area does this patent fall under?
Primary CPC classification C08L63/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).